Axon Enterprise AXON · NASDAQ
$414.43 -2.00% (-$8.46)
Summary
34 / 100 · Bulios Score
What speaks for it
- Revenue grew by 33% a year over the last 3 years.
- Analysts expect revenue to grow by 33% this fiscal year.
What to watch
- The share price is above the Bulios Fair Price.
- Earnings per share fell by 9.4% a year over the last 3 years.
- It earns only 1.1 USD a year on every 100 USD of invested capital.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensivePrice against the Bulios Fair Price
P/E against its own last 5 years
P/E against the industry (Aerospace & Defense)
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 167.4 USD for 1 USD of yearly profit. Over the last five years it was 192.8 USD on average.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 32% a year over 5 years. Over the last 3 years it grew by 33% a year. For the next fiscal year analysts expect revenue to grow by 33%. Earnings per share fell by 9.4% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 41 USD
- Research and development 22 USD
- Sales and administration 35 USD
- Taxes and other -3.6 USD
- Net profit 6.2 USD
Net profit, industry median (Aerospace & Defense) 23 USD
Out of every 100 USD of revenue, 6.2 USD is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 13.8 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 18
- Hold 4
- Sell 0
Today's price within the analysts' price targets
The average target of $652.14 is 57% above today's price. 82% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Software And Sensors Segment 43%
- TASER X2 33%
- Axon Body 14%
- Platform Solutions 9.6%
By region
- UNITED STATES 83%
- Non-US 17%
Software And Sensors Segment brings in 43% of revenue.
Segments in detail